A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly

Medicine (United States)

Volumn 95, Issue 52, 2016, Pages

  Wang, Peng ^a   Zhang, Dong ^a   Guo, Xue Guang ^a   Li, Xiao Mei ^a   Du, Le Hui ^a   Sun, Bao Jun ^a   Fang, Xiang Qun ^a   Guo, Ying Hua ^a   Guo, Jun ^a   An, Li ^a   Qu, Ge Ping ^a   Liu, Chang Ting ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Geriatric; Non Small Cell Lung Cancer; Stereotactic Body Radiotherapy; Surgery

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; CAUSE SPECIFIC SURVIVAL; CHARLSON COMORBIDITY INDEX; COMPARATIVE STUDY; CONTROLLED STUDY; EARLY CANCER; EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE SCORE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GERIATRIC PATIENT; HUMAN; INOPERABLE CANCER; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPENSITY SCORE; RECURRENCE FREE SURVIVAL; RECURRENT DISEASE; RESPIRATORY TRACT DISEASE ASSESSMENT; RETROSPECTIVE STUDY; SQUAMOUS CELL LUNG CARCINOMA; STEREOTACTIC BODY RADIATION THERAPY; THORACOTOMY; VERY ELDERLY; VIDEO ASSISTED THORACOSCOPIC SURGERY; WORLD HEALTH ORGANIZATION; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE FREE SURVIVAL; LUNG NEOPLASMS; MORTALITY; PROCEDURES; RADIOSURGERY; SURVIVAL ANALYSIS;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PROPENSITY SCORE; RADIOSURGERY; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 85010211121     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000005723     Document Type: Article

References (26)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7-30.
2. ChenW, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016;66:115-32.
3. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
4. Owonikoko TK, Ragin CC, Belani CP, et al. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol 2007;25:5570-7.
5. Detterbeck FC, Gibson CJ. Turning gray: the natural history of lung cancer over time. J Thorac Oncol 2008;3:781-92.
6. Vansteenkiste J, Crino L, Dooms C, et al. 2nd ESMO consensus conference on lung cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol 2014; 25:1462-74.
7. Verstegen NE, Oosterhuis JW, Palma DA, et al. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. Ann Oncol 2013;24: 1543-8.
8. Crabtree TD, Denlinger CE, Meyers BF, et al. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2010;140:377-86.
9. Shirvani SM, Jiang J, Chang JY, et al. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly. JAMA Surg 2014;149:1244-53.
10. van den Berg LL, Klinkenberg TJ, Groen HJ, et al. Patterns of recurrence and survival after surgery or stereotactic radiotherapy for early stage NSCLC. J Thorac Oncol 2015;10:826-31.
11. Grills IS, Mangona VS, Welsh R, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 2010;28:928-35.
12. Robinson CG, DeWees TA, El Naqa IM, et al. Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer. J Thorac Oncol 2013;8:192-201.
13. Crabtree TD, Puri V, Robinson C, et al. Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy. J Thorac Cardiovasc Surg 2014;147: 1183-92.e10.
14. Lee Y, Auh SL, Wang Y, et al. Therapeutic effects of ablative radiation on local tumor require CD8(+) T cells: changing strategies for cancer treatment. Blood 2009;114:589-95.
15. Timmerman R, Bastasch M, Saha D, et al. Optimizing dose and fractionation for stereotactic body radiation therapy. Normal tissue and tumor control effects with large dose per fraction. Front Radiat Ther Oncol 2007;40:352-65.
16. Hamaji M, Chen F, Matsuo Y, et al. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer. Ann Thorac Surg 2015;99:1122-9.
17. Palma D, Visser O, Lagerwaard FJ, et al. Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery. Radiother Oncol 2011;101:240-4.
18. Matsuo Y, Chen F, Hamaji M, et al. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: a propensity score matching analysis. Eur J Cancer 2014; 50:2932-8.
19. Shirvani SM, Jiang J, Chang JY, et al. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys 2012;84:1060-70.
20. Lagerwaard FJ, Verstegen NE, Haasbeek CJA, et al. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2012;83:348-53.
21. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005;63:1427-31.
22. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010;303:1070-6.
23. Donington JS. Point: are limited resections appropriate in non-small cell lung cancer? Yes. Chest 2012;141:588-90.
24. Chamogeorgakis T, Ieromonachos C, Georgiannakis E, et al. Does lobectomy achieve better survival and recurrence rates than limited pulmonary resection for T1N0M0 non-small cell lung cancer patients? Interact Cardiovasc Thorac Surg 2009;8:364-72.
25. Zhang B, Zhu F, Ma X, et al. Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: a systematic review and meta-analysis. Radiother Oncol 2014;112:250-5.
26. Mok TS, Wu Y-L, Thongprasert S, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009;361: 947-57.